Intestinal Enteroendocrine Cells are a diverse and specialized group of cells scattered throughout the lining of the gastrointestinal tract, with concentrations particularly high in the epithelium of the small intestine. Despite their relatively low abundance, these cells play a pivotal role in regulating digestive processes and nutrient homeostasis. Enteroendocrine cells produce and secrete various hormones, including cholecystokinin (CCK), gastrin, secretin, and peptide YY, among others. These hormones act locally within the gut or have systemic effects, influencing processes such as gastric acid secretion, pancreatic enzyme release, gut motility, and appetite regulation. Enteroendocrine cells are equipped with unique receptors that allow them to sense luminal contents, responding to changes in nutrient composition and signaling to the nervous system and other organs. This intricate communication network helps coordinate the complex interplay between digestion, absorption, and energy metabolism. Dysfunction of enteroendocrine cells has been implicated in conditions such as obesity, diabetes, and gastrointestinal disorders. Understanding the diverse functions and regulatory mechanisms of these cells is crucial for unraveling the complexities of gut physiology and holds implications for the development of targeted therapies addressing metabolic and digestive disorders.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Will be updated soon...
Vasiliki E Kalodimou, European University-Cyprus Ltd, Cyprus
Title : Will be updated soon...
Nagy Habib, Imperial College London, United Kingdom
Title : Will be updated soon...
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : Advanced 3D tissue models: Pioneering tools for investigating health and disease
Lucie Bacakova, Institute of Physiology of the Czech Academy of Sciences, Czech Republic
Title : Developing iPSC-derived 3D Outer Blood-Retinal Barrier Disease Models of Choroideremia for Gene Therapy Evaluation
Aradhana Kasimsetty, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), United States